After cancer drug counterfeiting scandal, India imposes new tracing requirements

In response to a recent scandal involving counterfeit cancer drugs, India has announced stringent new tracing requirements for pharmaceuticals. This move aims to enhance the integrity of the drug supply chain and protect patients from potentially harmful medications. The government is instituting a system that will track drugs from manufacturing to distribution, ensuring each batch is verified and traceable. The new regulations mandate the use of barcodes and QR codes on packaging, allowing authorities and consumers to authenticate products easily. This technological integration is expected to deter counterfeiters and provide a reliable way for pharmacies and hospitals to verify the origins of their supplies. Experts believe this step will significantly bolster consumer confidence and safety in an industry plagued by fraud. While the pharmaceutical sector acknowledges the necessity of these measures, some stakeholders express concerns about the implementation costs and logistics. Smaller manufacturers, in particular, may face challenges adapting to the new system. However, the government remains firm, asserting that the health and safety benefits far outweigh the initial hurdles. As India positions itself as a global pharmaceutical leader, these regulations represent a crucial step towards ensuring drug quality and patient safety.

— Authored by Next24 Live